← Leaderboards
Robert D. Bowles
Duke University
$2,806,318
Attributed
$2,806,318
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $429K · FY2013–25$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,806,318 · 4
By mechanism
R01$2,499,156 · 2
R03$223,500 · 1
F32$83,662 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Lori A. Setton$15,853,009
- Barbara Ramsay Shaw$2,698,175
- Pedro Gonzalez$2,848,992
- Jenny Tung$7,259,897
- Bryan R. Cullen$22,732,834
Others in their field
Top investigators on “Intervertebral Disc Structure”
- James C Iatridis · Icahn School Of Medicine At Mount Sinai$16,860,639
- Makarand V Risbud · Thomas Jefferson University$13,997,494
- Sharmila Majumdar · University Of California San Francisco$9,994,235
- Chitra L Dahia · Hospital For Special Surgery$7,231,640
- Jeffrey Charles Lotz · University Of California San Francisco$7,215,674
- Dawn M Elliott · University Of Delaware$6,803,161
Research focus
Intervertebral Disc StructureTissuesCellsBack PainMechanicsClustered Regularly Interspaced Short Palindromic RepeatsNeuronsLinkVectorGenesIntervertebral Disk DegenerationResponseNociceptionPainCytokineInflammationPathologyInflammatoryReceptorRegulationIn VivoMediatingInterleukin-6Inflammatory Response
Grant awards (12)
Novel Zinc-Finger Protein Regulator of Senescence and Cell Engineering$406,071
R01 · FY2025 · AR · contact PI
Novel Zinc-Finger Protein Regulator of Senescence and Cell Engineering$429,004
R01 · FY2024 · AR · contact PI
Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology$335,500
R01 · FY2023 · AR · contact PI
Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology$332,145
R01 · FY2022 · AR · contact PI
Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology$325,436
R01 · FY2021 · AR · contact PI
Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology$335,500
R01 · FY2020 · AR · contact PI
Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology$335,500
R01 · FY2019 · AR · contact PI
Sequence-Specific CRISPR Mediated Inflammatory Cytokine Receptor Modulation for the Treatment of Inflammatory Intervertebral Disc Pathology$74,500
R03 · FY2017 · AR · contact PI
Sequence-Specific CRISPR Mediated Inflammatory Cytokine Receptor Modulation for the Treatment of Inflammatory Intervertebral Disc Pathology$74,500
R03 · FY2016 · AR · contact PI
Sequence-Specific CRISPR Mediated Inflammatory Cytokine Receptor Modulation for the Treatment of Inflammatory Intervertebral Disc Pathology$74,500
R03 · FY2015 · AR · contact PI
Imaging NFkB Activity in Relation to Animal Behavior in Peripheral Neuropathy$31,472
F32 · FY2014 · AR · contact PI
Imaging NFkB Activity in Relation to Animal Behavior in Peripheral Neuropathy$52,190
F32 · FY2013 · AR · contact PI